Tag: FDA approval

2 predictions tagged with "FDA approval".

Synchron Files The First Premarket Approval (PMA) Application With The FDA For A Permanently Implanted BCI, The Stentrode, By The End Of 2027.
The First In Vivo CRISPR-Cas9 Gene Editing Therapy, Lonvoguran Ziclumeran (Lonvo-z), Is Expected To Receive US FDA Approval In 2027 For Hereditary Angioedema.